ADAMTS13 |
A disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 |
a-HUS |
Atypical hemolytic uremic syndrome |
ALT |
Alanine aminotransferase |
APTT |
Activated partial thromboplastin time |
AST |
Aspartate aminotransferase |
AT |
Antithrombin |
BMI |
Body mass index |
Ca |
Calcium |
Cl |
Chloride |
CRP |
C-reactive protein |
EMA |
European Medicines Agency |
FDA |
(American) Food and Drug Administration |
GT |
Gestational thrombocytopenia |
Hb |
Hemoglobin |
Hct |
Hematocrit |
HELLP |
Hemolysis (H), elevation of liver enzymes (EL) and low level of platelets (LP) |
HUS |
Hemolytic uremic syndrome |
ICU |
Intensive care unit |
ITP |
Immune thrombocytopenia |
K |
Potassium |
LDH |
Lactate dehydrogenase |
Mg |
Magnesium |
Na |
Sodium |
PE |
Preeclampsia |
PIH |
Pregnancy-induced hypertension |
STEC-HUS |
Hemolytic uremic syndrome caused by Escherichia coli infection producing Shiga toxin |
TMA(s) |
Thrombotic microangiopathies |
TTP |
Thrombotic thrombocytopenic purpura (TTP) |